Atlas Trials

NSABP Foundation Inc

66 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch NSABP Foundation Inc

RecordFirmDate
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE) (NCT07058012)NSABP Foundation Inc2026-04-17
A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy (NCT05178576)NSABP Foundation Inc2022-06-24
Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients (NCT03626922)NSABP Foundation Inc2019-05-15
Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer (NCT03628066)NSABP Foundation Inc2018-10-22
Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status (NCT03457896)NSABP Foundation Inc2018-05-18
Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling (NCT03412643)NSABP Foundation Inc2018-05-14
Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer (NCT03102047)NSABP Foundation Inc2018-05-14
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo (NCT03281954)NSABP Foundation Inc2017-12-19

Track NSABP Foundation Inc automatically

Every clearance here is in the API, with alerts when new ones post.